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Abstract
Background: Adenomyosis is a proliferative uterine dysfunction with unknown aetiology. One possible mechanism of
its development involves disturbances in stem cell differentiation in uterine tissue. Previously, we identified pluripotent/
multipotent cells in the bovine uterus, therefore our present study focused on determining expression of pluripotency
markers, NANOG, OCT4 and SOX2, in bovine adenomyotic tissues and cells.
Findings: Immunolocalisation revealed protein expression of NANOG, OCT4 and SOX2 in both normal and adenomyotic
uteri. mRNA expression for NANOG and OCT4 was increased in tissues obtained from uteri with adenomyosis compared
to controls, but at the protein level there were no significant differences. mRNA expression for all three pluripotency
markers was higher in myometrial cells isolated from uteri with adenomyotic lesions than in those isolated from normal
uteri. The protein level of NANOG and SOX2 was decreased in stromal cells from adenomyotic tissues, whereas the level
of OCT4 and SOX2 was increased in myometrial cells obtained from dysfunctional uteri.
Conclusions: The results indicate significant changes in expression of pluripotency markers in adenomyotic compared
to normal uteri, which suggest the involvement of uterine stem cells in adenomyosis.
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Background
Adenomyosis is uterine dysfunction characterised by the
presence of endometrial glands with stromal elements in
the myometrium [1]. This pathological condition is well
recognized in women, and although it is less known in
domestic animals including cows [2–4], nevertheless it
may result in reduced reproductive performance [4].
Although adenomyosis frequently occurs in multiparous
women [5] and cows older than 5 years [4], the aetiology
of this disorder is still unclear [2]. Several hypotheses
have been proposed to explain adenomyosis develop-
ment. One possible mechanism involves the breakdown
of endometrial and myometrial barrier preceded by
trauma such as abortion or gynaecological interventions,
and followed by reactive hyperplasia of the endometrium
and its proliferation within the myometrium [1, 6].
Another proposed mechanism of adenomyosis develop-
ment involves metaplasia of uterine pluripotent/multipo-
tent cells under hormonal stimuli. According to this
hypothesis, glandular nests may arise de novo within the
myometrial layer from undifferentiated stem cells under
specific conditions, in particular under the influence of
oestradiol (E2) [7, 8]. Whatever the mechanism under-
lying formation of glandular foci in the myometrium,
hormonal and immunological abnormalities certainly
play a role during adenomyosis development [9, 10].
Stem cells reside in many adult organs and tissues that
exhibit high regenerative potential [11]. The cells may be
identified by several markers, including NANOG, OCT4
and SOX2. These proteins are transcription factors
present in embryonic stem cells [12] and, as recent stud-
ies have shown, in mesenchymal stem cells settled also
in reproductive organs [13, 14]. OCT4 and SOX2 are
progenitor-specific proteins: octamer-binding transcrip-
tion factor 4 (OCT4) and sex determine region Ybox 2
(SOX2). NANOG is a homeodomain-containing tran-
scription factor and its expression is regulated by
OCT4/SOX2 heterodimer, which binds to the octamer/
sox elements at NANOG gene promoter [15]. In the
present study we selected NANOG, OCT4 and SOX2 as
the markers of undifferentiated state and pluripotency/
multipotency of cells that reside in uterus.
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Changes that occur in the endometrium during re-
productive cycles, in particular endometrial gland
morphogenesis, require a remarkable proliferation
capacity of the tissue; thus, pluripotent/multipotent
cells play an important role in endometrial function-
ing and renewal [11, 16, 17]. These proliferative pro-
cesses in the uterus remain under the strict control
of ovarian steroids, therefore these hormones also in-
fluence uterine stem cell properties [11, 17].
During adenomyosis in cows, protein expression of the
E2 receptor α (ERα) is increased [4], and also blood and
endometrial E2 concentrations are elevated, which indicate
hormonal abnormalities during this condition [4]. Parallel
with increased E2 stimulation, excessive proliferation of
endometrial cells occurs, which is characterized by expres-
sion of the proliferation marker KI-67-antigen in adeno-
myotic foci [18]. In our recent studies, we identified
pluripotent/multipotent cells in the bovine uterus [19].
We also demonstrated expression of the pluripotency
markers NANOG, OCT4 and SOX2 in uterine tissue and
cultured uterine primary epithelial, stromal and myome-
trial cells, and in addition we confirmed pluripotent/mul-
tipotent properties of these cells by multilineage
differentiation [19]. These results suggest that stem cells
may be involved in adenomyosis development in the
bovine uterus. Therefore, we hypothesized that pluripo-
tency markers NANOG, OCT4 and SOX2 are differen-
tially expressed in uterine tissues and cells from control
and adenomyotic cows. The study by Moreira et al. (2007)
showed increased frequency of adenomyosis in cows in
the mid luteal stage of the oestrous cycle [20], so for this
study we used uteri from cows at days 8–10 of the
oestrous cycle.
The aims of the study were: (1) comparison of
NANOG, OCT4 and SOX2 mRNA expression, immu-
nolocalisation and protein expression in control and
adenomyotic uterine tissues; (2) determination of
NANOG, OCT4 and SOX2 mRNA and protein
expression in cultured primary uterine endometrial




All procedures were approved by the Local Animal Care
and Use Committee, Olsztyn, Poland (agreement no. 83/
2012/N).
A total of 24 Holstein/Polish Black and White cows
(75 %/ 25 %, respectively) 5–7 years old were used for
post mortem collection of uteri (days 8–10 of the
oestrous cycle). Uterine tissues were obtained at the
Meat Processing Plant “Warmia” (Biskupiec, Poland)
and transported on ice to the laboratory within 40 min.
Day of the oestrous cycle was evaluated by macroscopic
observation of the ovaries and uterus [21] and confirmed
by determination of P4 levels in peripheral blood plasma
using radioimmunoassay (RIA). Just before slaughter,
each animal was examined by a veterinarian via per
rectum ultrasound-guided examination and information
about the age of each cow was recorded. Peripheral
blood samples were collected from the jugular vein. The
reasons for culling animals from the herd were eco-
nomic considerations and herd renewal. For further
experiments, after histopathologic examination, material
quality evaluation and hormone determination, 18 cows
were eventually selected (9 for each experimental group).
Tissue fragments (cross-sections of the uterine wall,
i.e., endometrium and myometrium) were obtained from
the middle segment of the uterine horn ipsilateral to the
corpus luteum and were divided into three pieces: the
first one was fixed in 4 % paraformaldehyde (PFA) in
0.1 M PBS (pH 7.4) for histo- and immunohistochemical
staining, the second was frozen and stored at −86 °C for
further mRNA and protein expression determination in
whole uterine tissue, and the third piece was used for
immediate isolation and culture of uterine cells.
Histochemical staining and preliminary division of the
material
Uterine tissue was fixed in 4 % PFA and processed for a
standard haematoxylin and eosin staining protocol.
Stained cross-sections of the tissue were observed under
a light microscope (Nikon FXA, Tokyo, Japan). Animals
were classified as described previously [4]; briefly, if
uterine glands were present only in the endometrium,
and if the endometrial-myometrial border was clearly
visible, cows were classified as normal/control (n = 9,
Fig. 1a). Whereas, if the glands penetrated the myome-
trial layer of the uterus, animals were classified as
adenomyotic (n = 9, Fig. 1b–d; according to the classifi-
cation of Katkiewicz et al. 2005 [18]).
Uterine cell isolation and in vitro culture
Endometrial stromal cells were isolated by enzymatic
dissociation as previously described [22]. After endomet-
rial cell isolation, the myometrial layer of the uterus was
accessed and dissected with scissors. About 4 cm long
fragments of muscle tissue were chopped up with scis-
sors into a homogeneous material. Approximately 5 g of
the chopped tissue was digested in 50 ml of M199
medium (Sigma, M2520, St. Louis, MO, USA) contain-
ing 0.1 % of bovine serum albumin (BSA; Sigma,
A2058), 20 μg/ml of gentamicin (Sigma, G1271), 2 mg/ml
of collagenase I (Sigma, C0130), 1 mg/ml of deoxyribo-
nuclease (Sigma, D5025) and 2 mg/ml of dispase (Life
Technologies, 17105–041, Paisley, UK). The enzyme solu-
tion with myometrial tissue was held at 37.5 °C with stir-
ring for 30 min. After digestion, the cell suspension was
Łupicka et al. Reproductive Biology and Endocrinology  (2015) 13:110 Page 2 of 13
filtered through a mesh to remove undigested tissue frag-
ments, then the cells were washed by centrifugation
(10 min at 100 x g, at 4 °C). Cells were resuspended in cul-
ture medium (DMEM; Sigma, D5796) supplemented with
10 % of fetal calf serum (FCS; Sigma, 12133C) and antibi-
otics (gentamicin/amphotericin B; Life Technologies,
1153727).
The cells of each layer of the uterus were seeded sep-
arately at a density of 1 x 106 living cells/ml in 1 ml and
2 ml culture medium per well in collagen-coated 24-well
and 6-well plates, respectively (Biocoat; BD Bioscience,
4408, 4400, Bedford, MA, USA), and cultured at 37.5 °C
in a humidified atmosphere of 5 % CO2, 95 % air. The
medium was changed every 2 days until 70 % confluence
was reached (approx. at 4th day of culture). Total
mRNA, cell lysates and culture media were collected.
Stromal cells maintained during culture fibroblast-like
morphology (Fig. 2a), while myometrial cells exhibited
fusiform appearance (Fig. 2b). Purity of the cell cultures
was rated by 4 independent observations under the light
microscope based on cells morphology [23], and was
evaluated for approx. 90–95 % for each cell types. Cell
culture homogeneity was also confirmed using real-time
PCR for determination of mRNA expression of vimentin
and desmin for stromal and myometrial cells, respect-
ively [23, 24]. Vimentin was highly expressed in stromal
cells and in contrary weakly expressed in myometrial cell
cultures (Fig. 2c). Desmin was expressed mainly in myo-
metrial cultures, while in stromal cultures the expression
was on low level (Fig. 2d). For cells’ functionality
confirmation prostaglandin (PG) E2 and PGF2α level was
measured in culture medium by enzyme immunoassay
(EIA; Fig. 3a, b). The levels of secreted PGs indicate
maintained functionality of the uterine cells during cul-
tures [25–27].
Immunohistochemistry
Immunohistochemistry (IHC) was used to localise
nuclear transcription factors, NANOG, OCT4 and
SOX2, in uterine tissues.
Cross-sections of uterine horn samples were fixed in
4 % PFA in 0.1 M PBS (pH 7.4), and cryoprotected in
18 % sucrose. Immunostaining was carried out on con-
secutive 7 μm cryostat sections. To block endogenous
peroxidase, the sections were treated with hydrogen per-
oxide in methanol and washed in 0.1 M PBS. The sec-
tions were blocked with 10 % normal goat serum
(Sigma, G9023) for 1 h at room temperature (approx.
23 °C; RT), incubated overnight at RT with a 1:100 dilu-
tion of anti-NANOG (Abcam, 80892, Cambridge, UK),
anti-OCT4 (Abcam, 19857) or anti-SOX2 (Sigma,
S9072) antibodies, washed in PBS, incubated for 1 h
with a 1:25,000 dilution of biotinylated anti-rabbit
(Vectastain ABC Kit; Vector Laboratories, PK 4001,
Burlingame, CA, USA) antibodies, then washed, incu-
bated for 45 min with the ABD reagent in PBS, and
washed again. Proteins were visualized by incubating
the sections in 0.3 mg/mL 3,30-diaminobenzidine tet-
rahydrochloride in 0.01 % hydrogen peroxide in Tris-
buffered saline (pH 7.2) for 2–3 min. Finally, the
Fig. 1 Representative pictures of haematoxylin and eosin stained bovine uterine cross-section slides. a – normal uterine tissue with regular, clearly
visible border between endometrium and myometrium; b-d – adenomyotic tissue with visible uterine glands within the myometrial layer of the
uterus. Arrows indicate glandular nests in myometrium. Scale bars: 100 μm
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sections were dehydrated and cover-slipped with DPX
mounting medium (Park Scientific Ltd, D-11601,
Northampton, UK). To determine the specificity of
the immunohistochemical staining, two controls were
performed: first, the primary antibody was omitted
during the immunostaining procedure; second, the
primary antibody was substituted with a nonspecific
IgG. Observations and photographs were made with a
light microscope (Nikon FXA).
Total RNA isolation
Total RNA was extracted from uterine tissues (approx.
30 mg) and cultured cells using TRI-Reagent (Sigma,
T9424) according to the manufacturer’s instructions.
The content and purity of RNA was assessed on a
NanoDrop 1000 (Thermo Fisher Scientific, ND-1000,
Wilmington, DE, USA). 260/280 absorbance ratio for
all samples was approx. 2.0, and 260/230 absorbance








































































Fig. 2 Evaluation of cell cultures homogeneity. a, b – representative pictures of stromal and myometrial cultured cells, respectively. Scale bars: 20 μm.
Expression of vimentin in stromal and myometrial cells c; expression of desmin in stromal and myometrial cells d. Data were normalized
against glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Bars represent the mean ± SEM. Asterisks indicate statistical difference between uterine
stromal and myometrial cells (P < 0.05), as determined by Student’s t-test
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sample of total RNA was reverse-transcribed to cDNA
with the QuantiTect Reverse Transcription kit (Life
Technologies, 205313), as described in the supplier’s
protocol. The cDNA obtained was stored at −20 °C
until real-time PCR was applied.
Real-time PCR quantification
mRNA expression for NANOG, OCT4 and SOX2 in the
tissues and cells was determined by quantitative real-
time PCR. The experiments were performed using the
Applied Biosystems 7900 (Applied Biosystems, Foster
City, CA, USA) with SensiFAST SYBR Hi-ROX Kit (Bio-
line Reagents, BIO-92002, London, UK) according to the
manufacturer’s instructions. The real-time PCR reaction
mix (20 μl) contained 19 μl of SensiFAST SYBR Hi-ROX
Master Mix, 0.5 μM of sense and antisense primers, and
1 μl of reverse-transcribed cDNA (50 ng). Primer se-
quences used for determination of vimentin, desmin,
NANOG, OCT4, SOX2 and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA expression are detailed
in Table 1. Standard curves consisting of serial dilutions
of the appropriate cDNA were plotted for efficiency
evaluation. Amplification was preceded by an initial en-
zyme activation step (2 min, 95 °C). The PCR steps were
as follows: 40 cycles of denaturation (5 s, 95 °C), then
annealing and extending (20 s, 60 °C). After amplifica-
tion, melting curves were acquired by stepwise increases
at a temperature of 50–95 °C to ensure that a single
product was amplified and no primer-dimer structures
were formed. Control reactions in the absence of the
template or primers were performed to confirm that
products were free from primer-dimers and genomic
DNA contamination, respectively. Dissociation curves
analysis was carried out after each real-time experiment
to confirm the presence of only one amplification prod-
uct. Data were normalized using the ΔΔCt method.
Samples were amplified in duplicates. Data are shown as
the average fold increase, with S.E.M., and are expressed
relative to the housekeeping gene GAPDH.
Western blotting
Protein expression for NANOG, OCT4 and SOX2 in the
tissues and cells was determined by Western blotting.
Proteins from homogenised tissues and in vitro cultured
cells were released by incubation with lysis buffer containing
50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 5 mM EDTA,
0.1 % SDS, 1 % TritonX-100, 0.5 % sodium deoxycholate
and protease inhibitors (Sigma, P8340). The lysates were
stored at −86 °C until further analysis. Protein concentra-
tions were measured by the Bradford’s method.
Western blot analysis was performed as previously
described [28]. Equal amounts of protein were dis-
solved in SDS gel-loading buffer, heated to 95 °C for
4 min and separated in 10 % SDS-PAGE. Separated
proteins were electroblotted onto 0.2 μm nitrocellu-
lose membranes in transfer buffer. After blocking in
5 % non-fat dry milk in TBS-T buffer for 1.5 h at RT, the
membranes were incubated overnight with a 1:250 dilution
of anti-NANOG (Novus Biologicals Ltd, NBP2-24941,
Cambridge, UK), a 1:400 dilution of anti-OCT4 (Novus
Biologicals Ltd, NB100-2379) or a 1:500 dilution of anti-
SOX2 (Sigma, S9072) antibodies; GAPDH (Sigma, G8795;
monoclonal anti-glyceraldehyde-3-phosphate dehydrogen-
ase antibody produced in mouse) expression was used as a
reference. Proteins were detected by incubating the mem-
branes with a 1:20,000 dilution of secondary polyclonal
anti-rabbit or anti-mouse alkaline phosphatase-conjugated
antibodies (Sigma, A 3687, A 3562) for 1.5 h at RT.
Western blots were quantitated using the Kodak 1 D
program (Eastman Kodak, Rochester, NY, USA).
Hormone determination
Measurements of P4 in blood plasma were performed
































Fig. 3 Prostaglandins secretion by stromal and myometrial cultured
cells. Secretion of prostaglandin E2 by cultured uterine cells a; secretion
of prostaglandin F2α by cultured uterine cells b. Bars represent
the mean ± SEM. There were no statistically significant differences
in PGs secretion between stromal and myometrial cells (P > 0.05),
as determined by Student’s t-test
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ImmunoAssays S.A., KIP1458, Nivelles, Belgium).
The standard curve ranged from 0.12–36 ng/ml and
the effective dose for 50 % inhibition (ED 50) of the
assay was 0.05 ng/ml. The intra- and inter-assay coeffi-
cients of variation (CV) were 6.5and 8.6 %, respectively.
Prostaglandins determination
Measurements of PGE2 and PGF2α levels in culture
media were performed using commercially available en-
zyme immunoassay kit (EIA kit; Cayman Chemical
Company, 514010 for PGE2 and 516011 for PGF2α, Ann
Arbor, MI, USA). Standard curve for PGE2 ranged from
9,5–5000 pg/ml and the effective dose for 50 % inhib-
ition (ED 50) of the assay was 15 pg/ml. The intra- and
inter-assay coefficients of variation (CV) were 4.2 % and
12.4 %, respectively. PGF2α standard curve ranged from
9,5–2000 pg/ml, ED 50 of the assay was 9 pg/ml and the
intra- and inter-assay CV were on average 9.4 % and
12 %, respectively.
Statistical analysis
Statistically significant differences between groups in the
experiments were evaluated using Student’s t-test
(GraphPad PRISM Version 5.00, San Diego, CA, USA).
All data were expressed as means ± SEM. Differences
were analysed between control and adenomyotic cows,
and were considered significant at P < 0.05.
Results
mRNA expression, immunolocalisation and protein
expression of pluripotency markers NANOG, OCT4 and SOX2
in uterine tissue of cows with adenomyosis
mRNA expression of transcription factors NANOG
and OCT4 was increased in adenomyotic uterine tissue
compared with normal uteri (P < 0.05, Fig. 4a, b).
There was no significant difference in SOX2 mRNA
expression between control and adenomyotic uteri
(P > 0.05, Fig. 4c).
Immunohistochemistry revealed expression of all three
pluripotency markers, NANOG, OCT4 and SOX2, in nor-
mal uterine tissues (Fig. 5c, e, g) as well as in adenomyotic
samples (Fig. 5d, f, h). The proteins examined were mainly
localised in the endometrium, however, in the case of ade-
nomyotic tissues the immunoreactivity was also high in the
myometrial compartment of the uterus and in adenomyo-
tic, ectopic glands (Fig. 5d, f, h).
At the protein expression level, determined by Western
blotting, there were no significant differences among
NANOG, OCT4 and SOX2 (P > 0.05, Fig. 6a–c). However
the spatial differences in examined proteins expression was
reported during IHC assay.
mRNA and protein expression of pluripotency markers
NANOG, OCT4 and SOX2 in uterine cells from cows with
adenomyosis
Expression of all genes of the three transcription factors
did not differ significantly between cultured stromal cells
isolated from adenomyotic uteri compared to those iso-
lated from control tissues (P > 0.05, Fig. 7a–c). Whereas,
mRNA expression of NANOG, OCT4 and SOX2 in cul-
tured uterine myometrial cells isolated from cows with
adenomyosis was increased compared to those isolated
from normal uteri (P < 0.05, Fig. 7d–f ).
Protein expression of NANOG and SOX2 was signifi-
cantly decreased in stromal cells isolated from uteri with
adenomyosis compared to those obtained from normal
uteri (P < 0.05, Fig. 8a, c). Protein expression of both
transcription factors OCT4 and SOX2 was higher in cul-
tured myometrial cells from adenomyotic tissues than in
Table 1 Oligonucleotide sequences used for real-time PCR
Gene Oligonucleotide sequences Product size GeneBank
(bp)
vimentin FWD 5’-GACCTGGAGCGTAAAGTGG-3’ 108 BC118269
REV 5’-GACATGCTGTTCTTGAATCTGG-3
desmin FWD 5’-GACCCAGGCAGCCAACAAG-3’ 100 BC133410
REV 5’-GTCGATCTCGCAGGTGTAGG-3’
NANOG FWD 5’-TGCATTTGCTGGAGACTGAG-3’ 107 DQ069776
REV 5’- GTCCCGGTCAAGAAACAAAA-3’
OCT4 FWD 5’-AGGTGTTCAGCCAAACGACTA-3’ 195 FD381287.1
REV 5’-TCTCCTGCAGATTCTCGTTGT-3’
SOX2 FWD 5’-GCACATGAACGGCTGGAGCAACG-3’ 218 JQ231229.1
REV 5’-TGCTGCGAGTAGGACATGCTGTAGG-3’
GAPDH FWD 5’-CACCCTCAAGATTGTCAGCA-3’ 103 BC102589
REV 5’-GGTCATAAGTCCCTCCACGA-3’
Łupicka et al. Reproductive Biology and Endocrinology  (2015) 13:110 Page 6 of 13
corresponding cells isolated from normal uteri (P < 0.05,
Fig. 8e, f ).
Discussion
Adenomyosis is a uterine proliferative dysfunction which
aetiology is still unclear. One possible mechanism of its
development implies the involvement of uterine stem
cells, which abnormal proliferation and differentiation
may lead to formation of glandular foci within the myo-
metrium [2, 12]. In our previous study, we confirmed
the existence of pluripotent/multipotent cells in the
bovine uterus [19]. The present research focused on
determining expression of pluripotency markers in ade-
nomyotic uterine tissues and cells. We confirmed that
pluripotency markers are expressed in adenomyotic
endometrial tissues and in glandular nests within the
myometrium, and that mRNA expression for NANOG
and OCT4 was higher in dysfunctional tissue compared
to the control; however, the tissue protein results deter-
mined by Western blotting did not confirm these differ-
ences. Moreover, we have demonstrated that both
mRNA and protein levels for OCT4 and SOX2 were in-
creased in cultured primary myometrial cells isolated
from adenomyotic uteri compared to the cells isolated
from normal tissues. However, in stromal cells protein
expression of NANOG and SOX2 was significantly de-
creased in the case of adenomyosis. To our knowledge,
this is the first study to report expression of pluripotency
markers in the bovine uterus with adenomyosis.
In women, the hypothesis of uterine stem cell involve-
ment in development of uterine dysfunction has been
widely studied [11, 29–31]. Moreover, the recent report
of Chen et al. (2014) showed increased expression of
another stem cell marker, Musashi-1, in adenomyotic
eutopic and ectopic endometrium of women [32]. The
presence of pluripotent/multipotent cells in the bovine
uterus suggests their possible role in development of
uterine dysfunction [19, 33, 34]. Nevertheless, there are
no studies on the involvement of pluripotent cells in
pathogenesis of adenomyosis or any other uterine dis-
eases in cows. Our present study is consistent with one
conducted in women [32], because we demonstrated in-
creased expression of pluripotency markers in myome-










































































































Fig. 4 mRNA expression of pluripotency markers NANOG a, OCT4 b and
SOX2 c in uterine tissues obtained from control cows and from cows
with adenomyosis. Data were normalized against glyceraldehyde-3-
phosphate dehydrogenase (GAPDH). Bars represent the mean ± SEM.
Asterisks indicate statistical difference between uterine normal and
adenomyotic tissues (P< 0.05), as determined by Student’s t-test. C –
tissues obtained from control cows, ADENO – tissues obtained from
cows with adenomyosis
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Fig. 5 Immunodetection of pluripotency markers in uterine tissues from control cows and from cows with adenomyosis. a, b – haematoxylin and
eosin stained slides of control and adenomyotic uterus, respectively; c, d – NANOG immunodetection in control and adenomyotic tissue, respectively;
e, f – immunolocalisation of OCT4 in normal and adenomyotic tissue, respectively; g, h – SOX2 immunodetection in control and adenomyotic tissue,
respectively; i, j, k – no Ab, negative controls for NANOG, OCT4 and SOX2, respectively. Unspecific IgG controls (pictures not shown) served similar pictures
as no Ab control. Arrows indicate the most intense histochemical reactions; dotted line indicate endometrial-myometrial border; e – endometrium, m –
myometrium, es – endometrial stroma, eg – endometrial gland, a – adenomyotic lesion, v – vessel. Scale bars: 20 μm
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whole uterine tissue, at the protein level evaluated by
Western blotting we did not find significant differences
in NANOG, OCT4 and SOX2 expression, in contrast to
our mRNA results. Moreover, mRNA expression of plur-
ipotency markers in stromal primary cells also did not
reflect protein expression. The reason for this inconsist-
ency may be posttranslational modifications of the pro-
teins, which results in different protein expression
pattern when comparing to mRNA. However in myome-
trial cells mRNA expression was consistent with protein
expression. These outcomes together with IHC results
indicate that the pattern of pluripotency markers expres-
sion in adenomyotic tissue may depends on the uterine
compartment: endometrium or myometrium. Our ex-
periments performed on the tissue showed general
expression of pluripotency markers in adenomyotic
uterus, which included its expression in stem cells that
migrate to uterus through blood and lymphatic vessels,
e.g. cells of medullary origin [31]. Whereas in vitro ex-
periment revealed pluripotency markers expression in
particular uterine cells, originated from endometrium or
myometrium. In our previous study we showed that the
main source of stem cells in the bovine uterus is stromal
layer [19], therefore we showed changed expression
pattern of pluripotency markers in case of uterine
pathology – adenomyosis.
In our study, we also demonstrated decreased protein
expression of NANOG and SOX2 in cultured primary
endometrial stromal cells from adenomyotic tissues
compared to the controls, which suggests that their
potential to differentiate into glands within the endomet-
rium may be reduced. Proliferation of endometrial cells
and formation of uterine glands is extremely important
for successful implantation and early embryo development
[35]. In high fertility heifers, endometrial expression of
genes involved in cell proliferation, tissue morphology
and development was increased when compared to
low fertility heifers [36]. Thus, during adenomyosis,
disturbed proliferative processes in the endometrium
of cows may impair their fertility [18, 37]. Moreover,
because the myometrium is a prolific source of pluripo-
tent cells during adenomyosis, this may imply a higher










































































































Fig. 6 Protein expression of NANOG a, OCT4 b and SOX2 c in
bovine uterine tissues obtained from control cows and from
cows with adenomyosis. Data were normalized against glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Bars represent the mean ± SEM.
There were no statistical differences between uterine normal and
adenomyotic tissues (P > 0.05), as determined by Student’s t-test.
Representative blots for NANOG, OCT4, SOX2 and GAPDH are
shown below the graphs d. MM – molecular weight marker, C –
tissues obtained from control cows, ADENO – tissues obtained
from cows with adenomyosis
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of the uterus, and may trigger the invasion of glandular
nests deep within.
Maintenance of uterine cell functions, including prolif-
eration, during cyclic endometrial remodelling is the
main factor underlying female fertility in many species
and is controlled by ovarian hormones [29, 37–39]. In
women, abnormalities in endometrial cell proliferation
potentially leads to development of gynaecological
diseases such as endometriosis, endometrial cancers and
adenomyosis [11, 29]. Bovine endometrial cell prolifera-
tion is also regulated by ovarian hormones: oestradiol
and progesterone [40]. Adenomyosis is an oestrogen-
dependent dysfunction [4, 30], thus it is suggested that
hormone disturbances may relate to uterine stem cell
functioning during adenomyosis [29]; however, this issue




















































































































































































































Fig. 7 mRNA expression of pluripotency markers in uterine cells isolated from control cows and from cows with adenomyosis. NANOG a OCT4
b and SOX2 c mRNA expression in uterine stromal cells. NANOG d OCT4 e and SOX2 f mRNA expression in uterine myometrial cells. Data were
normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Bars represent the mean ± SEM. Asterisks indicate statistical differences
between uterine normal and adenomyotic tissue (*P < 0.05; **P < 0.01), as determined by Student’s t-test. C – cells obtained from control cows,
ADENO – cells obtained from cows with adenomyosis
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endometrial glands to cyclic hormonal stimuli may con-
tribute to degenerative changes in the endometrium,
termed endometrosis, and result in decreased fertility
[41]. These changes are also linked to functional abnor-
malities of endometrial cells, especially impaired prolif-
eration activity in endometrotic glandular nests [39].
Although knowledge about the involvement of uterine
stem cells in pathogenesis of endometrosis is poor, re-
cent studies on mare infertility caused by this dysfunc-
tion suggest the utility of stem cell transplantation into
uteri for therapy. Stem cells that settled in degenerative
endometria during the experiments of Mambelli et al.
(2014) induced proliferation of glands and improved
their secretory functions [42]. These data suggest that a
wide range of uterine pathologies in different species
may be dependent on functions of uterine stem cells.
Therefore, our present study contributes by broadening
knowledge about this issue in cattle, which was not pre-
viously studied in this species.
Conclusions
In conclusion, our results indicate that significant changes
occur in the expression of pluripotency markers,
NANOG, OCT4 and SOX2, in bovine adenomyotic tis-
sues compared to normal uteri. Moreover, this expression
was dependent on the uterine compartment: in general, it
was decreased in the endometrial layer and the converse
in the myometrial layer. These data suggest the involve-
ment of uterine multipotent/pluripotent cells in develop-
ment of adenomyosis. Therefore our study imply that
stem cells play role not only under physiological condi-
tions but also in the case of uterine pathologies in cows.
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